z-logo
open-access-imgOpen Access
Towards the development of mechanism-based biomarkers to diagnose drug hypersensitivity
Author(s) -
Noé DuránFigueroa,
Jesús Agustín Badillo-Corona,
Dean J. Naisbitt,
José Luis Castrejón-Flores
Publication year - 2015
Publication title -
toxicology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.709
H-Index - 31
eISSN - 2045-4538
pISSN - 2045-452X
DOI - 10.1039/c4tx00238e
Subject(s) - hapten , drug , mechanism (biology) , drug development , medicine , pharmacology , immunology , antibody , philosophy , epistemology
T-cells are activated by different mechanisms in the presence of drugs, metabolites or haptens, and they release several molecules that can be used in the diagnosis of drug hypersensitivity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom